ORTHO CLINICAL DIAGNOSTICS H (OCDX) Stock Analyst Earnings Estimates
NASDAQ:OCDX - Nasdaq - GB00BMDNH979 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.802B 0.79% | 1.766B -1.96% | 2.043B 15.66% | 2.12B 3.80% | 2.238B 5.55% | 2.364B 5.60% | 2.447B 3.51% | 2.583B 5.58% | |
| EBITDA YoY % growth | 424.9M -6.27% | 414.3M -2.49% | 509M 22.86% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 97.4M -19.57% | 88.4M -9.24% | 180.9M 104.64% | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | 5.41% | 5.01% | 8.86% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | 0.81 132.59% | 0.91 11.82% | 1.04 14.86% | 1.19 14.71% | 1.34 12.53% | 1.54 14.79% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.19 16.03% | 0.23 9.77% | 0.25 39.40% | 0.25 22.31% | 0.23 26.37% | 0.29 23.89% | 0.31 21.95% |
| Revenue Q2Q % growth | 507.04M 2.95% | 538.982M 3.15% | 554.965M 6.52% | 536.094M 7.20% | 531.767M 4.88% | 575.861M 6.84% | 590.891M 6.47% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -20.88% | 0.21 | % | |
| Q4 2021 Q2Q % growth | 0.18 -5.26% | 0.15 | 0.03 | 16.67% |
| Q3 2021 Q2Q % growth | 0.21 | 0.15 | 0.06 | 44.54% |
| Q2 2021 Q2Q % growth | 0.16 | 0.14 | 0.02 | 10.68% |
| Q1 2021 Q2Q % growth | 0.26 | 0.16 | 0.10 | 58.32% |
| Q4 2020 Q2Q % growth | 0.19 | 0.20 | -0.01 | -4.82% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 500.1M -1.32% | 518.378M | -18.278M | -3.53% |
| Q4 2021 Q2Q % growth | 521M 0.85% | 531.596M | -10.596M | -1.99% |
| Q3 2021 Q2Q % growth | 522.5M 15.83% | 491.341M | 31.159M | 6.34% |
| Q2 2021 Q2Q % growth | 492.5M 26.12% | 486.64M | 5.86M | 1.20% |
| Q1 2021 Q2Q % growth | 506.8M | 487.083M | 19.717M | 4.05% |
| Q4 2020 Q2Q % growth | 516.6M 9.06% | 518.17M | -1.57M | -0.30% |
| Q3 2020 Q2Q % growth | 451.1M -0.46% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |